BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25799702)

  • 21. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
    Simionescu DT; Lovekamp JJ; Vyavahare NR
    J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanobacteria-associated calcific aortic valve stenosis.
    Jelic TM; Chang HH; Roque R; Malas AM; Warren SG; Sommer AP
    J Heart Valve Dis; 2007 Jan; 16(1):101-5. PubMed ID: 17315391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.
    Alexopoulos A; Bravou V; Peroukides S; Kaklamanis L; Varakis J; Alexopoulos D; Papadaki H
    Int J Cardiol; 2010 Mar; 139(2):142-9. PubMed ID: 19019468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood vessels and lymphatics in calcific aortic stenosis--in support of its inflammatory pathogenesis.
    Steiner I; Krbal L; Dominik J
    Cesk Patol; 2010 Apr; 46(2):33-6. PubMed ID: 21275223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of blood contact on the calcification of glutaraldehyde-pretreated porcine aortic valves.
    Ozaki S; Herijgers P; Flameng W
    Ann Thorac Cardiovasc Surg; 2003 Aug; 9(4):245-52. PubMed ID: 13129423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A strain-based finite element model for calcification progression in aortic valves.
    Arzani A; Mofrad MRK
    J Biomech; 2017 Dec; 65():216-220. PubMed ID: 29100595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis.
    Ortlepp JR; Pillich M; Schmitz F; Mevissen V; Koos R; Weiss S; Stork L; Dronskowski R; Langebartels G; Autschbach R; Brandenburg V; Woodruff S; Kaden JJ; Hoffmann R
    J Heart Valve Dis; 2006 Jul; 15(4):502-8. PubMed ID: 16901043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shear and endothelial induced late-stage calcific aortic valve disease-on-a-chip develops calcium phosphate mineralizations.
    Mendoza M; Chen MH; Huang P; Mahler GJ
    Lab Chip; 2022 Mar; 22(7):1374-1385. PubMed ID: 35234762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necropsy findings early after transcatheter aortic valve implantation for aortic stenosis.
    Roberts WC; Stoler RC; Grayburn PA; Hebeler RF; Ko JM; Brown DL; Brinkman WT; Mack MJ; Guileyardo JM
    Am J Cardiol; 2013 Feb; 111(3):448-52. PubMed ID: 23186601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
    Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
    Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of oral bacterial flora in calcific aortic stenosis: an animal model.
    Cohen DJ; Malave D; Ghidoni JJ; Iakovidis P; Everett MM; You S; Liu Y; Boyan BD
    Ann Thorac Surg; 2004 Feb; 77(2):537-43. PubMed ID: 14759434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
    Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
    J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Narrow and calcified aortic valve stenosis in subjects in their 8th and 9th decades. An anatomic study of 64 cases].
    Penther P; Boschat J; Etienne Y; Le Potier J; Gilard M
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):887-93. PubMed ID: 3142387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic analysis of interstitial aortic valve cells acquiring a pro-calcific profile.
    Renato M; Bertacco E; Franchin C; Arrigoni G; Rattazzi M
    Methods Mol Biol; 2013; 1005():95-107. PubMed ID: 23606251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weights of individual cusps in operatively-excised stenotic three-cuspid aortic valves.
    Roberts WC; Ko JM
    Am J Cardiol; 2004 Sep; 94(5):681-4. PubMed ID: 15342312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tezosentan inhibits uptake of proinflammatory endothelin-1 in stenotic aortic valves.
    Leskelä HV; Vuolteenaho O; Koivula MK; Taskinen P; Ruskoaho H; Peltonen T; Lehenkari P
    J Heart Valve Dis; 2012 Jan; 21(1):23-30. PubMed ID: 22474738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of leukotriene B4, transforming growth factor-beta1 and microparticles in relation to aortic valve calcification.
    Kochtebane N; Passefort S; Choqueux C; Ainoun F; Achour L; Michel JB; Bäck M; Jacob MP
    J Heart Valve Dis; 2013 Nov; 22(6):782-8. PubMed ID: 24597398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.
    Bossé Y; Miqdad A; Fournier D; Pépin A; Pibarot P; Mathieu P
    Circ Cardiovasc Genet; 2009 Oct; 2(5):489-98. PubMed ID: 20031625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralization and organic phase modifications as contributory factors of accelerated degeneration in homograft aortic valves.
    Lis GJ; Rokita E; Podolec P; Pfitzner R; Dziatkowiak A; Cichocki T
    J Heart Valve Dis; 2003 Nov; 12(6):741-51. PubMed ID: 14658816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD34-negative mesenchymal stem-like cells may act as the cellular origin of human aortic valve calcification.
    Nomura A; Seya K; Yu Z; Daitoku K; Motomura S; Murakami M; Fukuda I; Furukawa K
    Biochem Biophys Res Commun; 2013 Nov; 440(4):780-5. PubMed ID: 24120498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.